Navigation Links
Medisafe 1 Technologies Announces Delay in Closing $7MM Perpetual License Sale Due to Hurricane Sandy
Date:11/5/2012

JERUSALEM, November 5, 2012 /PRNewswire/ --

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the final pages which includes the review of the licensed contract by both parties for the closing of a $7MM non-exclusive perpetual license sale agreement have been postponed due to Hurricane Sandy.  The sale is currently on track to be completed on or around November 15.

As previously reported, the agreement will transfer rights for the full commercialization, marketing and distribution of its patented medicinal locking mechanism and bar-code matching system to a third party.  Terms of the sale include a one-time $7MM payment to Medisafe 1 Technologies.  

"Medisafe 1 Technologies looks forward to completing the sale and achieving a major milestone for our company in the coming days," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp.

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle.  Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact:
Jacob Elhadad, CEO
+972-524440000
Jacob.elhadad10@gmail.com


'/>"/>
SOURCE Medisafe 1 Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medisafe 1 Technologies Anticipates a Special Dividend of $0.01 (One Cent) to Each Shareholder of One Common Stock pending the $7MM Perpetual License Sale of Technology Rights
2. Medisafe 1 Technologies in Advanced Negotiations for $7MM Perpetual License Sale
3. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
4. Life Technologies Acquires Advanced Microscopy Group
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
6. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
7. Life Technologies Collaborates with USDA to Develop Same-Day, Multi-Strain E. coli Detection System
8. LightPath Technologies Provides Quarterly Update on Infrared Initiatives
9. Global eClinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies: MarketResearchReports.Biz
10. Harvest Technologies Corporation reicht Patentverletzungsklage gegen ThermoGenesis Corporation ein
11. Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... -- 7D Surgical announced today that it has ... and Drug Administration (FDA) and a medical device ... commercial launch of its innovative Machine-vision Image Guided ... Surgical System.  The 7D Surgical ... vision algorithms to eliminate the long-standing barriers to ...
(Date:1/23/2017)... WASHINGTON , Jan. 23, 2017 The ... of the Pharmacy and Medically Underserved Areas ... House of Representatives. The legislation, which was previously introduced ... improve patient access to health care through pharmacists and ... bill include Representatives Brett Guthrie (R-KY), ...
(Date:1/23/2017)... 23, 2017 Stock-Callers.com today presents the ... CPRX ), Sophiris Bio Inc. (NASDAQ: ... and Agile Therapeutics Inc. (NASDAQ: AGRX ). These ... lower in late trade on Friday, January 20 th , ... while shares of health care companies in the S&P 500 ...
Breaking Medicine Technology:
(Date:1/23/2017)... TAMPA, Fla. (PRWEB) , ... January 23, 2017 ... ... for the nonprofit educational institution’s inaugural K-20 Education Summit to be held March ... proposals to present by Jan. 25, 2017. , The keynote speakers include Dr. ...
(Date:1/23/2017)... ... 23, 2017 , ... The iaedp Foundation, recognized for its ... who treat the full spectrum of eating disorder problems, proudly announces the addition ... of the leading eating disorder treatments centers located throughout the U.S. As partners ...
(Date:1/23/2017)... Dc (PRWEB) , ... January 23, 2017 , ... ... American University is taught by healthcare management and evaluation leaders with decades of ... fee-for-service to pay-for-value in the United States healthcare system, there is a renewed ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... in North America for the scientific development, healthcare training and clinical application of ... and its 2017 AAT Member Certification Qualification Courses for Technicians, respectively. , For ...
(Date:1/23/2017)... ... January 23, 2017 , ... METTLER TOLEDO ... Process Chemistry by Applying Simple PAT Tools . , Crystallization is ... purify the desired product. Chemists now spend more time developing better intermediate ...
Breaking Medicine News(10 mins):